Perceptive Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
CM
CFM
CA
Perceptive Advisors's NAUT Position: Q2 2026 in Review
Perceptive Advisors reduced its Nautilus Biotechnolgy (NAUT) stake by 7.6% in Q2 2026, selling an estimated $2.53M and leaving 11,634,211 shares worth $21.8M. The position accounts for 0.33% of the portfolio, ranked #57.
Perceptive Advisors first reported a position in NAUT in Q2 2021 and has held it in 21 quarters since. The position peaked at $90M in Q2 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- Perceptive Advisors held 11,634,211 shares of Nautilus Biotechnolgy worth $21.8M as of Q2 2026.
- Perceptive Advisors sold 960,000 Nautilus Biotechnolgy shares in Q2 2026, an estimated $2.53M.
- Nautilus Biotechnolgy made up 0.33% of Perceptive Advisors's portfolio in Q2 2026, its #57 holding.
- Perceptive Advisors first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 21 quarters since.
- Perceptive Advisors's Nautilus Biotechnolgy position peaked at $90M in Q2 2021.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.